D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.42% |
| 2 | Technology | 18.55% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 8.5% |
| 5 | Healthcare | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
LIMNW
4351
Liminatus Pharma Warrants
LIMNW
$336K
| $3.33K | ﹤0.01% |
83,353
| – | – |
2025 Q2
3 quarters
|
|
4352
Scage Future Warrants
SCAGW
$113K
| $3.33K | ﹤0.01% |
68,749
| – | – |
2025 Q2
3 quarters
|
|
4353
Aspire-Lakewood Holdings, Inc. Warrant
ASBPW
$158
| $3.32K | ﹤0.01% |
199,999
| – | – |
2022 Q2
15 quarters
|
|
4354
Able View Global Warrant
ABLVW
$120K
| $3.3K | ﹤0.01% |
200,000
| – | – |
2023 Q3
10 quarters
|
|
4355
Southland Holdings Warrants
SLND.WS
$1.03M
| $3.21K | ﹤0.01% |
91,666
| – | – |
2021 Q4
17 quarters
|
|
4356
Psyence Biomedical Warrant
PBMWW
$199K
| $3.17K | ﹤0.01% |
175,352
| – | – |
2024 Q1
8 quarters
|
|
4357
SunPower Inc Warrants
SPWRW
$393K
| $3.1K | ﹤0.01% |
12,382
| – | – |
2021 Q3
18 quarters
|
|
4358
DELISTED
Keen Vision Acquisition Corp Warrant
KVACW
| $2.93K | ﹤0.01% |
97,000
| – | – |
2023 Q3
10 quarters
|
|
4359
CDT Equity Inc Warrant
CDTTW
$775K
| $2.81K | ﹤0.01% |
375,000
| – | – |
2022 Q2
15 quarters
|
|
4360
Prenetics Global Ltd Warrant
PRENW
$110K
| $1.83K | ﹤0.01% |
104,515
| – | – |
2022 Q3
14 quarters
|
|
4361
ZOOZ Strategy Ltd Warrant
ZOOZW
| $1.8K | ﹤0.01% |
55,752
| – | – |
2024 Q2
7 quarters
|
|
4362
MultiSensor AI Holdings Warrant
MSAIW
$715K
| $1.42K | ﹤0.01% |
31,500
| – | – |
2021 Q4
17 quarters
|
|
|
GIBOW
4363
GIBO Holdings Warrants
GIBOW
| $1.39K | ﹤0.01% |
50,000
| – | – |
2025 Q2
3 quarters
|
|
4364
ECARX Holdings Warrants
ECXWW
| $1.2K | ﹤0.01% |
20,340
| – | – |
2022 Q4
13 quarters
|
|
4365
Cardio Diagnostics Holdings Inc Warrant
CDIOW
$72.3K
| $1.12K | ﹤0.01% |
74,822
| – | – |
2022 Q1
16 quarters
|
|
4366
XBP Europe Holdings Warrant
XBPEW
| $1.1K | ﹤0.01% |
19,714
| – | – |
2021 Q3
18 quarters
|
|
4367
Hub Cyber Security Warrant 2/27/28
HUBCW
$130K
| $313 | ﹤0.01% |
51,318
| – | – |
2023 Q1
12 quarters
|
|
4368
DELISTED
Lanvin Group Holdings Warrants
LANV.WS
| $275 | ﹤0.01% |
25,000
| – | – |
2022 Q4
13 quarters
|
|
4369
Beneficient Warrant
BENFW
$151K
| $244 | ﹤0.01% |
19,500
| – | – |
2023 Q2
11 quarters
|
|
4370
Gogoro Inc Warrant
GGROW
$139K
| $227 | ﹤0.01% |
44,527
| – | – |
2022 Q2
15 quarters
|
|
4371
American Assets Trust
AAT
$1.33B
| – | – |
-10,752
| Closed | -$204K | – |
|
4372
PUT
AbbVie
ABBV
$485B
| – | – |
-43,800
| Closed | -$10M | – |
|
4373
AbCellera Biologics
ABCL
$4.09B
| – | – |
-77,776
| Closed | -$266K | – |
|
4374
Abacus Global Management
ABX
$794M
| – | – |
-10,099
| Closed | -$86.3K | – |
|
4375
PUT
Airbnb
ABNB
$97.6B
| – | – |
-486,700
| Closed | -$66.1M | – |
|
Similar funds
D.E. Shaw & Co's Q1 2026 Portfolio in Review
As of Q1 2026, D.E. Shaw & Co held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $5.92B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in Venture Global Inc worth $211M.
- D.E. Shaw & Co's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- D.E. Shaw & Co added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- D.E. Shaw & Co opened 685 new positions and closed 756 in Q1 2026.
- D.E. Shaw & Co's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.